clodronic acid has been researched along with Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auriola, SO; Mönkkönen, J; Taskinen, M; Urtti, A | 1 |
Peck, WA | 1 |
Gray, RE; Greaves, M; Hamdy, NA; Kanis, JA; McCloskey, EV; Neil, FE; Preston, FE; Urwin, GH; Yates, AJ | 1 |
1 trial(s) available for clodronic acid and Leukemia
Article | Year |
---|---|
Results of a randomized study of clodronate in treating cancer-related hypercalcemia.
Topics: Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Leukemia; Neoplasms; Random Allocation | 1987 |
2 other study(ies) available for clodronic acid and Leukemia
Article | Year |
---|---|
Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.
Topics: Animals; Calcium; Cell Division; Cell Line; Chlorocebus aethiops; Clodronic Acid; Delayed-Action Preparations; Diphosphonates; Drug Carriers; Etidronic Acid; Humans; Kidney; Leukemia; Liposomes; Macrophages; Mice; Pamidronate; Phagocytes; Tumor Cells, Cultured | 1994 |
Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Topics: Adult; Aged; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Kidney Tubules; Leukemia; Male; Middle Aged; Neoplasms | 1987 |